Cases
Cases 1 - 10 of 86
THERAVANCE BIOPHARMA R&D IP, LLC et al v. QILU PHARMACEUTICAL CO., LTD. et al
as 2:2024cv02689
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: QUI PHARMACEUTICAL CO., LTD. and Qilu Pharma Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2024cv00150
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant: LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
as 1:2023cv02843
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MYLAN PHARMACEUTICALS INC. et al v. SANOFI-AVENTIS U.S. LLC et al
as 2:2023cv00836
Plaintiff: MYLAN PHARMACEUTICALS INC., MYLAN SPECIALTY L.P. and MYLAN INC.
Defendant: SANOFI-AVENTIS U.S. LLC, SANOFI S.A., AVENTIS PHARMA S.A. and others
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
Theravance Biopharma R&D IP, LLC et al v. Lupin Inc. et al
as 1:2023cv00187
Plaintiff: Theravance Biopharma R&D IP, LLC, Theravance Biopharma Ireland Limited, Theravance Biopharma US, Inc. and others
Defendant: Lupin Inc., Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ACCORD HEALTHCARE, INC. et al
as 1:2023cv00157
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS LTD.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mylan Inc. et al v. Medimpact Healthcare Systems, Inc.
as 3:2023cv00213
Plaintiff: Mylan Inc. and Mylan Specialty L.P.
Defendant: Medimpact Healthcare Systems, Inc.
Cause Of Action: 28 U.S.C. § 1331 Fed. Question

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?